This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Chinese Academy of Sciences. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Baohong Jiang: Inventor of a Pharmaceutical Composition for Ischemic Injury
Introduction
Baohong Jiang is an inventor based in Shanghai, China, associated with the Chinese Academy of Sciences. His patent work focuses on a pharmaceutical composition intended to help prevent or treat ischemic diseases and tissue or organ damage caused by ischemia-reperfusion.
Latest Patents
The available information lists 1 patent for Baohong Jiang: “Pharmaceutical Composition and Application Thereof.” The composition combines salvianolic acid B as its first active ingredient with ginsenoside Rg1 as its second active ingredient, at a weight ratio of 5:(1–4.5). The patent describes this proportion as offering improved therapeutic efficacy compared with prior art and proposes applications across different tissues and organs affected by ischemia or ischemia-reperfusion injury.
Career Highlights
Jiang’s listed patent reflects research into combining active ingredients for potential therapeutic use. The invention addresses ischemic conditions and ischemia-reperfusion damage, with the stated aim of supporting treatment across a range of affected tissues and organs.
Collaborations
The listed coworkers associated with Jiang are Xiaoyu Wang and Rongrong Xing. The available information does not specify their individual contributions to the patent.
Conclusion
Baohong Jiang’s patent centers on a salvianolic acid B and ginsenoside Rg1 composition designed for potential use against ischemic diseases and ischemia-reperfusion injury.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile